Deep search
Search
Images
Copilot
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Medicare to Negotiate Prices for 15 More Drugs, Including Ozempic
Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities, federal health officials announced in a news release. The negotiations,
HHS Selects 15 New Drugs for Medicare Part D Price Negotiations
As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices expected to take effect in 2027.
Government picks 15 more prescription drugs for Medicare price negotiation
The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has selected 15 additional drugs for pr
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks around drugs including Novo Nordisk’s Wegovy, GSK’s Trelegy Ellipta, and Pfizer’s Xtandi will set Medicare prices that go into effect in 2027.
Trump Reverses Some Biden Drug Pricing Initiatives, Potentially Impacting Medicare Costs
Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.
Trump rolls back effort to lower Medicare, Medicaid drug costs
Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.
Trump cancels Biden’s rule to help Medicare lower prescription drug prices
Drug pricing experts are not sure why rolling back drug pricing initiatives would be a day one priority for President Trump.
Yes, Trump rescinded Biden's order to lower prescription drug costs for people on Medicare and Medicaid
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started, so current drug prices are unaffected.
Lawmakers oppose Trump’s reversal on Medicare drug prices
Concern is growing among Democrats after President Donald Trump reversed some of the former president’s executive orders, including efforts to reduce prescription drug costs for Medicare and
Trump Revokes Biden's Order to Lower Drug Prices for Medicare
President Trump rescinded a Biden-era Executive Order that would have lowered the copays for some drugs to $2 for Medicare enrollees.
2d
Departed Biden Medicare Chief Lauds Landmark Drug Negotiations
Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo ...
STAT
8d
Former Trump White House, HHS aide Abe Sutton likely to lead Medicare, Medicaid innovation center
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
Scripps News on MSN
5d
Xavier Becerra reflects on tenure as HHS secretary: 'We're leaving this country healthier and stronger'
Xavier Becerra is reflecting on tenure as HHS secretary. He told Scripps News, "We're leaving this country is healthier and ...
5d
on MSN
Latest Medicare price drug negotiations includes Ozempic, Wegovy
Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...
JD Supra
5d
EnforceMintz —Could the Supreme Court’s Decision in Jarkesy Mean the End to HHS Civil Monetary Penalty Authorities as We Know Them?
Last June, the Supreme Court issued its decision in Securities and Exchange Commission v. Jarkesy, which holds that the ...
Iowa Public Radio
3h
Federal health agencies told to halt all external communications
In a memo obtained by NPR, acting health secretary Dorothy Fink forbade staff from public communications on most matters ...
Skilled Nursing News
6h
Legal Defeat Remains Key Even if Legislative, Administrative Barriers Make Repeal of the Nursing Home Staffing Mandate Inevitable
In the aftermath of the Department of Health and Human Services’ (HHS) response to a pending lawsuit against the federal ...
12h
CMS Doubles Down on Medicare Drug Price Controls, Threatening Patient Access and Innovation
ARLINGTON, VIRGINIA / ACCESS Newswire / January 22, 2025 / The Centers for Medicare & Medicaid Services (CMS) has announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback